Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints

Journal of Clinical Oncology

Volumn 32, Issue 19, 2014, Pages 2031-2038

  Deprez, Sabine ^a   Vandenbulcke, Mathieu ^a   Peeters, Ronald ^a   Emsell, Louise ^a   Smeets, Ann ^a   Christiaens, Marie Rose ^a   Amant, Frederic ^a   Sunaert, Stefan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEMATODAL AGENT;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN REGION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; ECHO PLANAR IMAGING; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; LONGITUDINAL STUDY; MEDICAL INFORMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; TASK PERFORMANCE AND ANALYSIS;

EID: 84905855331     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.6219     Document Type: Article

References (47)

1. Wefel JS, Schagen SB: Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12:267-275, 2012
2. Ahles TA, Saykin AJ: Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192-201, 2007
3. Ahles TA, Saykin AJ, McDonald BC, et al: Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 110: 143-152, 2008 (Pubitemid 351793851)
4. Hermelink K, Untch M, Lux MP, et al: Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer 109:1905-1913, 2007 (Pubitemid 46668557)
5. Wefel JS, Saleeba AK, Buzdar AU, et al: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348-3356, 2010
6. Jim HS, Phillips KM, Chait S, et al: Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dosechemotherapy. J Clin Oncol 30:3578-3587, 2012
7. Inagaki M, Yoshikawa E, Matsuoka Y, et al: Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146-156, 2007 (Pubitemid 46120202)
8. McDonald BC, Conroy SK, Ahles TA, et al: Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Res Treat 123:819-828, 2010
9. McDonald BC, Conroy SK, Smith DJ, et al: Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain Behav Immun 30:S117-S125, 2013
10. Deprez S, Amant F, Smeets A, et al: Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30:274-281, 2012
11. Deprez S, Amant F, Yigit R, et al: Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480-493, 2011
12. de Ruiter MB, Reneman L, Boogerd W, et al: Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33:2971-2983, 2012
13. Koppelmans V, de Groot M, de Ruiter MB, et al: Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Hum Brain Mapp 35:889-899, 2014
14. Koppelmans V, de Ruiter MB, van der Lijn F, et al: Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 132:1099-1106, 2012
15. Kesler S, Janelsins M, Koovakkattu D, et al: Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun 30:S109-S116, 2013
16. Hosseini SM, Koovakkattu D, Kesler SR: Altered small-world properties of gray matter networks in breast cancer. BMC Neurol 12:28, 2012
17. Silverman DH, Dy CJ, Castellon SA, et al: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103:303-311, 2007 (Pubitemid 46944511)
18. Ferguson RJ, McDonald BC, Saykin AJ, et al: Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866-3870, 2007 (Pubitemid 47477262)
19. Kesler SR, Bennett FC, Mahaffey ML, et al: Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res 15:6665-6673, 2009
20. de Ruiter MB, Reneman L, Boogerd W, et al: Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32:1206-1219, 2011
21. Kesler SR, Kent JS, O'Hara R: Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68:1447-1453, 2011
22. McDonald BC, Conroy SK, Ahles TA, et al: Alterations in brain activation during working memory processing associated with breast cancer and treatment: A prospective functional magnetic resonance imaging study. J Clin Oncol 30:2500-2508, 2012
23. López Zunini RA, Scherling C, Wallis N, et al: Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: A prospective fMRI study. Brain Imaging Behav 7:460-477, 2013
24. Ramsey NF, Koning HA, Welles P, et al: Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain 125:1793-1807, 2002
25. Nagel IE, Preuschhof C, Li SC, et al: Performance level modulates adult age differences in brain activation during spatial working memory. Proc Natl Acad Sci U S A 106:22552-22557, 2009
26. Stern Y, Rakitin BC, Habeck C, et al: Task difficulty modulates young-old differences in network expression. Brain Res 1435:130-145, 2012
27. Deprez S, Vandenbulcke M, Peeters R, et al: The functional neuroanatomy of multitasking: Combining dual tasking with a short term memory task. Neuropsychologia 51:2251-2260, 2013
28. Spielberger CD: Assessment of state and trait anxiety: Conceptual and methodological issues. South Psychol 2:6-16, 1985
29. Bosscher RJ, Koning H, Van Meurs R: Reliability and validity of the Beck Depression Inventory in a Dutch college population. Psychol Rep 58:696-698, 1986
30. Schmand B, Bakker D, Saan R, et al: [The Dutch Reading Test for Adults: A measure of premorbid intelligence level] [in Dutch]. Tijdschr Gerontol Geriatr 22:15-19, 1991
31. Broadbent DE, Cooper PF, FitzGerald P, et al: The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21:1-16, 1982 (Pubitemid 12093480)
32. Corbetta M, Shulman GL: Control of goaldirected and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201-215, 2002 (Pubitemid 135706590)
33. Majerus S, Bastin C, Poncelet M, et al: Short-term memory and the left intraparietal sulcus: Focus of attention? Further evidence from a face short-term memory paradigm. Neuroimage 35:353-367, 2007 (Pubitemid 46240948)
34. Majerus S, Poncelet M, Van der Linden M, et al: The left intraparietal sulcus and verbal short-term memory: Focus of attention or serial order? Neuroimage 32:880-891, 2006 (Pubitemid 44149151)
35. Gillebert CR, Mantini D, Thijs V, et al: Lesion evidence for the critical role of the intraparietal sulcus in spatial attention. Brain 134:1694-1709, 2011
36. Logan GD, Gordon RD: Executive control of visual attention in dual-task situations. Psychol Rev 108:393-434, 2001 (Pubitemid 33610302)
37. Posner MI, Rothbart MK: Attention, selfregulation and consciousness. Philos Trans R Soc London B Biol Sci 353:1915-1927, 1998
38. Medalla M, Barbas H: Anterior cingulate synapses in prefrontal areas 10 and 46 suggest differential influence in cognitive control. J Neurosci 30:16068-16081, 2010
39. Burgess PW: Strategy application disorder: The role of the frontal lobes in human multitasking. Psychol Res 63:279-288, 2000
40. Abraham J, Haut MW, Moran MT, et al: Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer 8:88-91, 2008 (Pubitemid 351346234)
41. Deprez S, Billiet T, Sunaert S, et al: Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: A review. Brain Imaging Behav 7:409-435, 2013
42. Cimprich B, Reuter-Lorenz P, Nelson J, et al: Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324-331, 2010
43. Scherling C, Collins B, Mackenzie J, et al: Prechemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: An FMRI study. Front Hum Neurosci 5:122, 2011
44. Scherling C, Collins B, Mackenzie J, et al: Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study. J Clin Exp Neuropsychol 34:543-560, 2012
45. Gleason CE, Schmitz TW, Hess T, et al: Hormone effects on fMRI and cognitive measures of encoding: Importance of hormone preparation. Neurology 67:2039-2041, 2006 (Pubitemid 44967386)
46. Craig MC, Fletcher PC, Daly EM, et al: Physiological variation in estradiol and brain function: A functional magnetic resonance imaging study of verbal memory across the follicular phase of the menstrual cycle. Horm Behav 53:503-508, 2008
47. Dietrich T, Krings T, Neulen J, et al: Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage 13:425-432, 2001 (Pubitemid 34185001)